SCHEMBL4184785

SCHEMBL4184785

CC(C)(C)OC(=O)Nc1ccc(CC(N)CN)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 3/20 0.52
PPARG P37231 2/20 0.49
PPARA Q07869 1/20 0.49
DRD2 P14416 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.44
MAPK14 Q16539 1/20 0.44
ITGB3 P05106 1/20 0.42
ITGB1 P05556 1/20 0.42
ITGAV P06756 1/20 0.42
ITGA2B P08514 1/20 0.42
ITGB5 P18084 1/20 0.42
AURKA O14965 1/20 0.42
RPS6KB1 P23443 1/20 0.42
NAMPT P43490 2/20 0.41
PSMB8 P28062 1/20 0.41
MAPKAPK2 P49137 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16856562 0.90 CYP17A1 (0.53) CYP17A1PPARGPPARADRD2PTGDR2
SCHEMBL20204187 0.90 CYP17A1 (0.53) CYP17A1PPARGPPARADRD2PTGDR2
SCHEMBL28747809 0.86 PPARG (0.50) CYP17A1PPARGPPARADRD2PTGDR2
SCHEMBL27577525 0.86 PPARG (0.50) CYP17A1PPARGPPARADRD2PTGDR2
SCHEMBL27916490 0.86 CYP17A1 (0.54) CYP17A1PPARGPPARADRD2PTGDR2
SCHEMBL7955771 0.84 PPARA (0.50) CYP17A1PPARGPPARADRD2PTGDR2
SCHEMBL20215005 0.84 AURKA (0.47) CYP17A1PPARGAURKARPS6KB1HDAC1
SCHEMBL7955775 0.84 PPARA (0.50) CYP17A1PPARGPPARADRD2PTGDR2
SCHEMBL21689917 0.83 PPARG (0.55) CYP17A1PPARGPPARADRD2PTGDR2
SCHEMBL2617177 0.83 PPARG (0.55) CYP17A1PPARGPPARADRD2PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2021335-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF C-FMS KINASE Janssen Pharmaceutica, N.V. (BE) 2009-02-11 EP disclosed
WO-2007124316-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-01 WO disclosed